Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Medicure Inc

Market Cap 10.44M 7.44M 6.42M 5.9M 5.55M 702M 10.52M 69.93M 27.22M 345M 27.92M 27.33M 1.19B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 7.49M 5.34M 4.61M 4.24M 3.99M 504M 7.56M 50.2M 19.54M 247M 20.05M 19.62M 856M EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
73.4%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 79 1997-09-14
Director of Finance/CFO - 2022-05-31
Chief Tech/Sci/R&D Officer - 2019-06-30
Director TitleAgeSince
Chairman 79 1997-09-14
Director/Board Member 92 2000-02-27
Director/Board Member 56 2013-01-21
Change 5-day change 1-year change 3-year change Capi.($)
-5.23%+0.16% - - 7.98M
+3.23%+2.25%+65.02%+113.87% 54.54B
+0.04%+1.20%+47.67%+36.75% 43.86B
+3.04%+7.05%-12.15%-18.06% 22.63B
+3.07%+7.15%-1.82%+392.25% 20.7B
+3.08%+2.14%+23.06%-34.52% 15.84B
+5.27%+1.87%+13.67%-38.81% 14.83B
+0.65%-0.27%+26.80%+174.70% 13.1B
+1.44%+2.94%+18.51% - 12.66B
+1.92%+2.43%+112.68%+232.59% 11.68B
Average +1.50%+2.14%+32.60%+107.35% 23.31B
Weighted average by Cap. +2.22%+2.15%+37.14%+98.47%

Financials

2024 2025
Net sales 21.91M 15.62M 13.47M 12.39M 11.66M 1.47B 22.09M 147M 57.15M 723M 58.61M 57.36M 2.5B 28.86M 20.57M 17.75M 16.31M 15.36M 1.94B 29.1M 193M 75.27M 953M 77.2M 75.55M 3.3B
Net income -1.04M -741K -639K -587K -553K -69.9M -1.05M -6.96M -2.71M -34.3M -2.78M -2.72M -119M -7.1M -5.06M -4.36M -4.01M -3.78M -477M -7.16M -47.55M -18.51M -234M -18.99M -18.58M -811M
Net Debt -6.32M -4.5M -3.88M -3.57M -3.36M -425M -6.37M -42.33M -16.48M -209M -16.9M -16.54M -722M -2.94M -2.1M -1.81M -1.66M -1.57M -198M -2.97M -19.73M -7.68M -97.2M -7.88M -7.71M -336M
Logo Medicure Inc
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!